ArticleDiagnostic pathology2024
Benign Metastasizing Leiomyoma: New insights into a rare disease with an obscure etiopathogenesis.
Article in Diagnostic pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 12 citations in OpenAlex.
- Late-onset pulmonary benign metastasizing leiomyoma 3 decades after hysterectomy: A case report.Radiology case reports · 2026Article
- Incidental pulmonary leiomyoma in a patient with invasive mucinous breast carcinoma: A diagnostic challenge.Radiology case reports · 2026Article
- Beyond the uterus: Metastatic leiomyoma.Journal of clinical imaging science · 2026Article
- Recurrent Uterine Smooth Muscle Tumor of Uncertain Malignant Potential in a Postmenopausal Woman After Total Abdominal Hysterectomy With Bilateral Salpingo-Oophorectomy: A Case Report.Case reports in pathology · 2026Article
- Case Report: Pulmonary fibroleiomyomatous hamartoma presenting as a giant exophytic multilocular cystic lesion.Frontiers in medicine · 2026Article
- Pulmonary Benign Metastasizing Leiomyoma in a Patient With a Concurrent Breast Tumor: A Diagnostic Challenge.Cureus · 2025Article
- Leiomyomas beyond the uterus presenting with multiple growth patterns in a single patient.BMC women's health · 2025Article
- Pulmonary Benign Metastasizing Leiomyoma: A Retrospective Analysis of Seven Cases Including a Rare Coexistence with In Situ Mucinous Adenocarcinoma.Biomedicines · 2025Article
- Benign Metastasizing Leiomyoma in a Patient With No Known History of Uterine Leiomyomas.Cureus · 2024Article
- Leiomyogenic Tumor of the Spine: A Systematic Review.Cancers · 2024Review
- Diverse Presentations of Extrauterine Leiomyomas in the Female Urogenital Tract: A Retrospective Series of 51 Cases.Journal of mid-life healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBenign metastasizing leiomyoma (BML) is a rare disease with an unknown etiopathogenesis that mostly affects middle-aged women with uterine leiomyoma. Many metastatic nodules outside the uterus characterize the condition. The metastases are smooth muscle lesions without malignancy. Morphologically and immunohistochemically, they resemble uterine leiomyomas, indicating a shared clonal origin. The lungs are the most prevalent site for incidental metastasis detection. BML has a relatively slow progression and good prognosis, and historically, there has been a lack of established guidelines for its treatment. CASE PRESENTATION: Herein, we report a case of BML in a patient with multiple metastases. Through extensive histological and immunohistochemical analyses, this complex case enabled not only the definitive diagnosis of BML, but also shed light on its complex etiopathogenesis.
conclusionThis study presents novel histology evidence suggesting a potential causal relationship between metaplasia and the development of BML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.